Related Experiment Video
Updated: Jan 30, 2026

The Use of Drip Flow and Rotating Disk Reactors for Staphylococcus aureus Biofilm Analysis
Published on: December 27, 2010
Fighting Staphylococcus aureus Biofilms with Monoclonal Antibodies
Dina Raafat1, Michael Otto2, Kevin Reppschläger3
1Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Egypt; Current affiliation: Department of Immunology, University Medicine Greifswald, Greifswald, Germany.
Antibodies offer a promising strategy against Staphylococcus aureus (S. aureus) biofilms, which are difficult to treat. This review explores antibody mechanisms and passive vaccination for S. aureus infections.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Staphylococcus aureus (S. aureus) is a major cause of biofilm-related infections.
- S. aureus biofilms resist antibiotic treatment and host immune responses.
- Novel strategies are needed to combat these persistent infections.
Purpose of the Study:
- To review mechanisms of anti-S. aureus antibodies against biofilms.
- To provide an overview of monoclonal antibodies in clinical trials.
- To highlight passive vaccination strategies and future research directions.
Main Methods:
- Literature review of S. aureus biofilm infections.
- Analysis of antibody mechanisms in combating biofilms.
- Survey of current clinical trials and passive vaccination research.
Main Results:
- Anti-S. aureus antibodies can disrupt biofilm structure and enhance immune clearance.
- Several monoclonal antibodies targeting S. aureus are in clinical development.
- Passive vaccination strategies show potential for preventing and treating biofilm infections.
Conclusions:
- Antibody-based approaches are a viable therapeutic strategy against S. aureus biofilms.
- Further research into antibody targets and passive vaccination is warranted.
- Targeting S. aureus biofilms with antibodies could overcome current treatment limitations.
More Related Videos
Related Concept Videos
Biofilms
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Population Growth
The Sympathetic Nervous System

